Late Outcomes After Transcatheter Aortic Valve Implantation with Balloon-Versus Self-Expandable Valves: Meta-Analysis of Reconstructed Time-To-Event Data

Cardiol Clin. 2024 Aug;42(3):373-387. doi: 10.1016/j.ccl.2024.02.017. Epub 2024 Mar 27.

Abstract

Self-expanding valves (SEV) and balloon-expandable valves (BEV) for transcatheter aortic valve implantation (TAVI) have their own features. There is a growing interest in long-term outcomes with the adoption of lifetime management in younger patients. To evaluate late outcomes in TAVI with SEV versus BEV, we performed a study-level meta-analysis of reconstructed time-to-event data published by May 31, 2023. We found no statistically significant difference in all-cause death after TAVI with SEV versus BEV. Randomized controlled trials are warranted to validate our results.

Keywords: Aortic valve; Cardiac surgical procedures; Cardiovascular surgical procedures; Heart valve prosthesis implantation; Meta-analysis; Transcatheter aortic valve replacement.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Aortic Valve Stenosis* / surgery
  • Aortic Valve* / surgery
  • Heart Valve Prosthesis*
  • Humans
  • Prosthesis Design*
  • Time Factors
  • Transcatheter Aortic Valve Replacement* / methods
  • Treatment Outcome